SEC Form 4 · accession 0001209191-17-065956
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Saoud
Officer — SVP and Head of R&D
Period of report
Dec 13, 2017
Accepted (ET)
Dec 15, 2017 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.10 | Dec 13, 2017 | A | 175,000 | A | — | Dec 13, 2027 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter.